Results 261 to 270 of about 216,413 (307)
Some of the next articles are maybe not open access.
Current Medicinal Chemistry, 2008
Pharmacological studies highlighted pleiotropic effects of statins, that seem to influence atherogenesis not only by increasing atherosclerotic plaque stability but also by modulating endothelial function and inflammation and acting on platelet aggregation and thrombosis.
Bersano A +5 more
openaire +3 more sources
Pharmacological studies highlighted pleiotropic effects of statins, that seem to influence atherogenesis not only by increasing atherosclerotic plaque stability but also by modulating endothelial function and inflammation and acting on platelet aggregation and thrombosis.
Bersano A +5 more
openaire +3 more sources
All for Statins and Statins for All; An Update
Current Pharmaceutical Design, 2015Statins exert beneficial effects on cardiovascular [CV] outcomes as well as on inflammation and oxidative stress. The widespread use of statins for both primary and secondary CV disease prevention is based on the evidence from large randomized controlled trials. The benefits of statin treatment outweigh any harm in high risk patients. In this narrative
Aris P, Agouridis +3 more
openaire +2 more sources
Current Atherosclerosis Reports, 2021
Chronic inflammation has been recognized as one of the most important pathophysiological mechanisms' initiation and progression of atherosclerosis. Statins belong to most successful therapeutic agents in the prevention and treatment of atherothrombotic vascular disease.
Martin Satny +2 more
openaire +2 more sources
Chronic inflammation has been recognized as one of the most important pathophysiological mechanisms' initiation and progression of atherosclerosis. Statins belong to most successful therapeutic agents in the prevention and treatment of atherothrombotic vascular disease.
Martin Satny +2 more
openaire +2 more sources
Anti-Cancer Agents in Medicinal Chemistry, 2014
Statins have pleiotropic properties and might exert an effect even in the field of cancer. Statins competitively inhibit 3-hydroxy-3-methylglutaryl coenzyme (HMG-CoA) reductase, the major rate-limiting enzyme that controls the conversion of HMG-CoA to mevalonic acid.
Natalia G, Vallianou +3 more
openaire +2 more sources
Statins have pleiotropic properties and might exert an effect even in the field of cancer. Statins competitively inhibit 3-hydroxy-3-methylglutaryl coenzyme (HMG-CoA) reductase, the major rate-limiting enzyme that controls the conversion of HMG-CoA to mevalonic acid.
Natalia G, Vallianou +3 more
openaire +2 more sources
Journal of Obstetrics and Gynaecology Canada, 2003
Hydroxymethylglutaryl coenzyme A (HMG CoA) reductase inhibitors, otherwise known as statins, are the most common class of lipid lowering medications prescribed today. Although this class of medications is contraindicated in pregnant women and those trying to conceive, there are many individuals who would benefit from these medications.
openaire +2 more sources
Hydroxymethylglutaryl coenzyme A (HMG CoA) reductase inhibitors, otherwise known as statins, are the most common class of lipid lowering medications prescribed today. Although this class of medications is contraindicated in pregnant women and those trying to conceive, there are many individuals who would benefit from these medications.
openaire +2 more sources
Medical Clinics of North America, 2012
3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitor medications, commonly referred to as statins, are among the most widely prescribed medications. Variation in individual response to statins concerning low-density lipoprotein cholesterol reduction, clinical event benefit, and side effects has been observed. Some of this variability is attributed
H Robert, Superko +2 more
openaire +2 more sources
3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitor medications, commonly referred to as statins, are among the most widely prescribed medications. Variation in individual response to statins concerning low-density lipoprotein cholesterol reduction, clinical event benefit, and side effects has been observed. Some of this variability is attributed
H Robert, Superko +2 more
openaire +2 more sources
Current Medicinal Chemistry, 2019
Background: Stroke is a major cause of mortality and disability in modern societies. Statins are effective medications in decreasing cardiovascular events through lipid lowering and pleiotropic effects. Objective: To summarize current evidence regarding the role of statins in the prevention and management of stroke. Methods: A narrative review of
Konstantinos, Aznaouridis +3 more
openaire +2 more sources
Background: Stroke is a major cause of mortality and disability in modern societies. Statins are effective medications in decreasing cardiovascular events through lipid lowering and pleiotropic effects. Objective: To summarize current evidence regarding the role of statins in the prevention and management of stroke. Methods: A narrative review of
Konstantinos, Aznaouridis +3 more
openaire +2 more sources
Hearing Research, 2022
Statins are a class of drugs that are widely used for the treatment of hyperlipidemia and the prevention of heart attack and stroke. These drugs inhibit the rate-limiting step in the synthesis of cholesterol, HMG-CoA reductase. In addition, statins have effects unrelated to cholesterol, stemming from the non-cholesterol synthesizing arms of the HMG-CoA
openaire +2 more sources
Statins are a class of drugs that are widely used for the treatment of hyperlipidemia and the prevention of heart attack and stroke. These drugs inhibit the rate-limiting step in the synthesis of cholesterol, HMG-CoA reductase. In addition, statins have effects unrelated to cholesterol, stemming from the non-cholesterol synthesizing arms of the HMG-CoA
openaire +2 more sources
Trends in Pharmacological Sciences, 2003
The withdrawal of cerivastatin from the world market because of deaths from rhabdomyolysis (a disorder that results from skeletal muscle injury with release of muscle cell contents into the plasma) focused attention on the risk of adverse events and, in particular, myotoxicity that are associated with statins.
Lin, Yan +3 more
openaire +4 more sources
The withdrawal of cerivastatin from the world market because of deaths from rhabdomyolysis (a disorder that results from skeletal muscle injury with release of muscle cell contents into the plasma) focused attention on the risk of adverse events and, in particular, myotoxicity that are associated with statins.
Lin, Yan +3 more
openaire +4 more sources
Current Opinion in Obstetrics & Gynecology, 2013
The use of statins in women of reproductive age to prevent adverse cardiovascular events is on the rise. This is attributed to an increase in metabolic risk factors such as obesity, raised lipids, diabetes and high blood pressure. Statins are contraindicated in pregnancy because of the perceived increased risk of congenital abnormalities to the foetus.
Suzanna, Morton, Shakila, Thangaratinam
openaire +2 more sources
The use of statins in women of reproductive age to prevent adverse cardiovascular events is on the rise. This is attributed to an increase in metabolic risk factors such as obesity, raised lipids, diabetes and high blood pressure. Statins are contraindicated in pregnancy because of the perceived increased risk of congenital abnormalities to the foetus.
Suzanna, Morton, Shakila, Thangaratinam
openaire +2 more sources